Medical Device News Magazine

ExtriCARE USA Launches Innovative Medical Device Company, Offering Negative Pressure Wound Therapy Solutions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

ExtriCARE USA  a national medical device company specializing in the distribution of negative pressure wound therapy (NPWT), officially announces its company launch and new user-centric website.

ExtriCARE USA, led by President Peter Mason, who has over eight years of industry experience, is fostering the future of healthcare with wound care technologies that improve patient outcomes, help clinicians with efficiency and reduce overall costs. NPWT is a modern resource still in its infancy stage. With a tailored and hands-on approach, the ExtriCARE USA team is working diligently to amplify its potential.

“I have a driving passion to develop reliable NPWT products for our network of dealers, which in turn helps patients live a better-quality life,” said Mason. “I am excited to continue building strong partnerships with dealers nationwide, allowing us to support patients and clinicians alike while reaching new heights of growth together.”

To coincide with the company’s launch, ExtriCARE USA has built a new website designed with the user in mind. The website has in-depth information on the ExtriCARE product line, the leadership team and press page with the company’s latest insights.

“With over a decade of experience in wound care, I am fortunate and proud to be a part of such a dynamic and forward-thinking team,” said Gary Schear, Vice President of Sales. “Our patient-first mentality is a driving force, and we hope to continue being a trustworthy lifeline for our providers so that they can be the lifeline for their patients.”

The ExtriCARE USA leadership team, comprised of Peter Mason, Gary Schear and Tony Cheung (Director of Operations), is committed to the future of NPWT. In partnership with Alleva Medical, the company is introducing a new product line that will transform traditional NPWT. The products are designed to be versatile, featuring state-of-the-art technology and optimized software. ExtriCARE USA and Alleva Medical will bring these portable, powerful and adaptive solutions to the market soon.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”